v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (5,601,126) $ (3,638,193)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 122,778 107,729
Share-based compensation 106,811 84,257
Amendment of warrants 0 48,087
Non-cash settlements 0 58,272
Change in fair value related to warrants and derivative (18) (11,766)
Change in operating assets and liabilities    
Accounts receivable 1,508 (2,595)
Prepaids and other current assets (129,339) (232,111)
Accounts payable 372,842 (268,237)
Accrued and other liabilities (172,352) (521,837)
Net cash used in operating activities (5,298,896) (4,376,394)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Intangible assets – Patents (90,716) (121,810)
Fixed assets (1,808) (480)
Net cash used in investing activities (92,524) (122,290)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Public offering of common stock and warrants 0 14,554,545
Registered direct offerings of common stock 1,036,000 5,167,927
Proceeds from direct offering of prefunded warrants 9,323,982 0
Common stock cash issuance costs (698,889) (1,959,643)
Exercise of Series C warrants 0 336,441
Redemption of Series B Preferred stock 0 (1,213,590)
Net cash provided by financing activities 9,661,093 16,885,680
Net increase in cash, cash equivalents and restricted cash 4,269,673 12,386,996
Cash, cash equivalents and restricted cash, beginning of period 12,040,789 463,661
Cash, cash equivalents and restricted cash, end of period 16,310,462 12,850,657
Cash paid for interest 0 0
Cash paid for income taxes 800 0
Non-cash activities    
Capitalization of Series B preferred stock dividends 0 5,425
Capitalization of Series C preferred stock dividends 0 1,258
Conversion of Series C preferred stock to common stock 0 548,534
Cashless exercise of B warrants to common stock $ 0 $ 9,539,081